Lifemd, Inc. (LFMD): Modelo de negócios Canvas [Jan-2025 Atualizado]

No cenário em rápida evolução da saúde digital, a Lifemd, Inc. (LFMD) surge como uma plataforma de telessaúde pioneira que reimagina o acesso médico e o atendimento ao paciente. Ao misturar perfeitamente a tecnologia de ponta com soluções abrangentes de saúde, a empresa transforma as interações médicas tradicionais em experiências digitais convenientes e personalizadas que atendem às necessidades dinâmicas de saúde dos consumidores modernos. Esse modelo de negócios inovador representa uma abordagem estratégica para democratizar a assistência médica, alavancando a tecnologia para quebrar barreiras geográficas e logísticas, fornecendo serviços médicos eficientes e sob demanda que ressoam com gerações experientes em tecnologia que buscam alternativas de saúde flexíveis e acessíveis.

Lifemd, Inc. (LFMD) - Modelo de negócios: Parcerias -chave

Plataformas de tecnologia de telessaúde

A LifeMD faz parceria com as principais plataformas de tecnologia da TeleHealth para fornecer serviços de saúde digital.

Parceiro da plataforma	Capacidades de tecnologia	Status de integração
Teladoc Health	Consulta em vídeo compatível com HIPAA	Integração ativa
Amwell	Gerenciamento seguro de dados do paciente	Integração parcial

Provedores de saúde e profissionais médicos

A LifeMD colabora com profissionais médicos licenciados em várias especialidades.

• Médicos certificados pelo conselho: 127
• Enfermeiros: 43
• Áreas especializadas: cuidados primários, saúde sexual, gerenciamento de peso

Agências de marketing digital e publicidade

As parcerias estratégicas de marketing digital oferecem suporte a aquisição de clientes e conscientização da marca.

Agência	Foco de marketing	Gasto anual
Assistentes de conversão	Marketing de desempenho digital	US $ 1,2 milhão
Saúde de alcance da saúde	Publicidade direcionada para a saúde	$875,000

Redes de seguro de saúde

A LIFEMD mantém parcerias com provedores de seguros selecionados para expandir a cobertura do paciente.

• Aetna: cobertura parcial para serviços de telessaúde
• Cigna: reembolso de consulta de telessaúde
• United Healthcare: integração de rede limitada

Serviços de comércio eletrônico e prescrição

Parcerias com redes de distribuição farmacêutica permitem gerenciamento de prescrição.

Parceiro de cumprimento	Escopo de serviço	Prescrições mensais
Farmácia Alto	Entrega de medicamentos direta ao paciente	12,500
Cápsula	Gerenciamento de prescrição digital	8,750

Lifemd, Inc. (LFMD) - Modelo de negócios: Atividades -chave

Serviços de consulta de telemedicina

A LIFEMD registrou 276.000 consultas totais no terceiro trimestre de 2023, com uma receita de US $ 14,9 milhões para serviços de telessaúde durante esse trimestre. O tempo médio de consulta é de 15 a 20 minutos por interação do paciente.

Métrica de consulta	Q3 2023 dados
Total de consultas	276,000
Receita de telessaúde	US $ 14,9 milhões
Duração média da consulta	15-20 minutos

Diagnóstico e tratamento de saúde digital

A LIFEMD oferece serviços de diagnóstico digital em várias especialidades médicas:

• Cuidados primários
• Saúde sexual
• Saúde mental
• Gerenciamento de peso

Gerenciamento de prescrição on -line

Estatísticas de atendimento à prescrição digital para 2023:

Categoria de prescrição	Volume anual
Prescrições totais emitidas	412,000
Taxa de atendimento de prescrição digital	87%

Desenvolvimento de Programas de Condição e Bem -Estar Crônica

As principais áreas de foco do programa incluem:

• Gerenciamento de diabetes
• Monitoramento de hipertensão
• Programas de perda de peso
• Apoio à saúde mental

Aprimoramento da tecnologia de plataforma contínua

Investimento de tecnologia para 2023: US $ 3,2 milhões alocados ao desenvolvimento de plataformas e melhorias em infraestrutura tecnológica.

Área de investimento em tecnologia	2023 Alocação
Desenvolvimento da plataforma	US $ 1,8 milhão
Atualizações de infraestrutura	US $ 1,4 milhão

Lifemd, Inc. (LFMD) - Modelo de negócios: Recursos -chave

Plataforma de software de telessaúde proprietária

A partir do quarto trimestre 2023, a plataforma TeleHealth da Lifemd suporta Mais de 150.000 consultas de pacientes anualmente. A plataforma integra várias especialidades médicas a uma infraestrutura de tecnologia no valor de aproximadamente US $ 4,2 milhões.

Capacidade da plataforma	Especificação
Consultas anuais dos pacientes	150,000+
Valor da infraestrutura da plataforma	US $ 4,2 milhões
Investimento em tecnologia	US $ 1,8 milhão (2023)

Rede de profissionais médicos licenciados

Lifemd mantém uma rede de 387 médicos licenciados em várias especialidades.

• Médicos certificados pelo conselho: 245
• Enfermeiros: 92
• Consultores médicos especializados: 50

Experiência em saúde digital e conhecimento médico

Os recursos intelectuais da empresa incluem 12 Protocolos de saúde digital proprietários cobrindo várias condições médicas.

Dados do paciente e sistemas de informação de saúde

O sistema de informação de saúde da Lifemd gerencia 478.000 registros de pacientes com a infraestrutura de gerenciamento de dados compatível com HIPAA.

Métrica de gerenciamento de dados	Valor
Total de registros de pacientes	478,000
Investimento anual de segurança de dados	US $ 1,2 milhão

Infraestrutura de tecnologia e recursos de segurança cibernética

Lifemd investe US $ 2,5 milhões anualmente em infraestrutura de segurança cibernética e tecnologia.

• Redundância da infraestrutura em nuvem: 99,99% de tempo de atividade
• Padrões de criptografia: AES-256
• Conformidade anual de auditoria de segurança cibernética: SOC 2 Tipo II

Lifemd, Inc. (LFMD) - Modelo de negócios: proposições de valor

Serviços de saúde convenientes e acessíveis

A LIFEMD relatou 174.000 pacientes no terceiro trimestre de 2023, com visitas de saúde digital representando um canal de prestação de serviços importantes.

Métrica de serviço	2023 desempenho
Visitas totais de pacientes digitais	174,000
Tempo médio de consulta do paciente	15-20 minutos

Consultas médicas sob demanda

A LIFEMD oferece consultas virtuais de saúde em várias especialidades médicas.

• Serviços de telessaúde de cuidados primários
• Consultas de saúde mental
• Serviços de Saúde Sexual
• Programas de gerenciamento de peso

Planos de tratamento personalizados

A LIFEMD gerou receita de US $ 41,1 milhões no terceiro trimestre de 2023, com planos de tratamento personalizados contribuindo significativamente para o envolvimento do paciente.

Segmento de tratamento	Contribuição da receita
Medicamentos prescritos	US $ 18,5 milhões
Consultas de telessaúde	US $ 12,3 milhões

Alternativas de cuidados médicos econômicos

O custo médio de consulta da LifeMD varia entre US $ 50 e US $ 75, significativamente menor que as visitas médicas tradicionais pessoais.

Soluções abrangentes de gerenciamento de saúde digital

A LIFEMD relatou 88% de taxa de satisfação do paciente em 2023, indicando uma forte eficácia da gestão da saúde digital.

Métrica de Saúde Digital	2023 desempenho
Taxa de satisfação do paciente	88%
Repetir a taxa de paciente	62%

Lifemd, Inc. (LFMD) - Modelo de negócios: relacionamentos com o cliente

Plataformas de autoatendimento digital

A plataforma digital da LIFEMD permite que os pacientes:

• Agende consultas virtuais
• Acesse registros médicos
• Solicite recargas de prescrição
• Questionários de saúde online completos

Métrica da plataforma	2023 dados
Usuários totais de plataforma digital	87,342
Usuários ativos mensais	42,156
Duração média da sessão do usuário	12,4 minutos

Sistemas automatizados de comunicação de pacientes

O LIFEMD utiliza canais de comunicação automatizados, incluindo:

• Lembretes por e -mail
• Notificações de nomeação do SMS
• Pesquisas de acompanhamento automatizadas

Canal de comunicação	Taxa de engajamento
Lembretes por e -mail	68.3%
Notificações de SMS	72.1%

Rastreamento e recomendações de saúde personalizados

Os recursos de personalização incluem:

• Painéis de saúde personalizados
• Ferramentas de rastreamento específicas da condição
• Recomendações de tratamento personalizadas

Consultas de acompanhamento virtual

Métrica de consulta	2023 Estatísticas
Total de consultas virtuais	64,289
Duração média da consulta	18,6 minutos
Taxa de satisfação do paciente	89.4%

Canais de suporte ao cliente 24/7

Canal de suporte	Tempo médio de resposta
Bate -papo ao vivo	3,2 minutos
Suporte telefônico	7,5 minutos
Suporte por e -mail	4,6 horas

Lifemd, Inc. (LFMD) - Modelo de Negócios: Canais

Aplicativo móvel

A partir do quarto trimestre 2023, o aplicativo móvel da LIFEMD serve como um canal digital primário para interações com os pacientes.

Métricas de aplicativos móveis	Pontos de dados
Downloads de aplicativos totais	237,000
Usuários ativos mensais	89,500
Duração média da sessão do usuário	12,4 minutos

Plataforma de telessaúde baseada na Web

A plataforma da Web da Lifemd fornece serviços de telessaúde abrangentes em várias especialidades médicas.

Estatísticas da plataforma da web	Figuras
Consultas virtuais anuais	425,000
Duração média da consulta	18 minutos
Disponibilidade da plataforma	50 estados dos EUA

Marketing digital direto ao consumidor

Os canais de marketing digital impulsionam a aquisição e o engajamento dos pacientes.

• Gastes de publicidade digital em 2023: US $ 4,2 milhões
• Custo de aquisição de clientes: US $ 87 por paciente
• Taxa de conversão de campanhas de marketing: 3,6%

Engajamento da mídia social

Plataforma de mídia social	Contagem de seguidores	Taxa de engajamento
Instagram	42,500	2.7%
Facebook	65,300	1.9%
LinkedIn	18,700	1.4%

Parcerias com prestadores de serviços de saúde

As colaborações estratégicas expandem o alcance do serviço e o acesso ao paciente.

• Total de Parcerias de Provedores de Saúde: 127
• Cobertura da rede: 38 estados
• Volume anual de referência: 156.000 pacientes

Lifemd, Inc. (LFMD) - Modelo de negócios: segmentos de clientes

Millennials e Gen Z buscando assistência médica conveniente

De acordo com o Pew Research Center, a partir de 2023, a geração do milênio (com idades 27-42) e a geração Z (com idades 11-26) representam aproximadamente 42% da população total dos EUA. As taxas de adoção de saúde digital para esses dados demográficas são estimados em 68%.

Faixa etária	Porcentagem populacional	Adoção digital da saúde
Millennials	26.8%	65%
Gen Z	15.5%	72%

Pacientes com condições crônicas

Os dados do CDC de 2022 indicam que 6 em 10 adultos dos EUA têm pelo menos uma doença crônica, representando aproximadamente 133 milhões de indivíduos.

• Diabetes: 37,3 milhões de pacientes
• Hipertensão: 47% dos adultos
• Doença cardíaca: 18,2 milhões de adultos

Indivíduos com acesso limitado à saúde

As estatísticas de saúde rural mostram que 46 milhões de americanos vivem em áreas com escassez de provedores de serviços de saúde.

Região	População	Limitação de acesso à saúde
Áreas rurais	46 milhões	57% de acesso limitado

Consumidores preocupados com a saúde

A pesquisa de mercado de bem -estar indica que 79% dos consumidores priorizam a assistência médica preventiva em 2023.

• Verificações de bem -estar de telessaúde: 62% de juros
• Demanda de triagem preventiva: US $ 16,5 bilhões no mercado

Populações remotas e com conhecimento digital

A utilização da telessaúde atingiu 38% dos adultos dos EUA em 2023, com crescimento contínuo projetado.

Demográfico	Uso de telessaúde	Preferência de saúde digital
18-34 anos	45%	72%
35-54 anos	36%	65%

Lifemd, Inc. (LFMD) - Modelo de negócios: estrutura de custos

Desenvolvimento e manutenção de tecnologia

Despesas anuais de tecnologia para LIFEMD A partir do quarto trimestre 2023: US $ 4,2 milhões

Categoria de custo de tecnologia	Despesa anual
Desenvolvimento de software	US $ 1,7 milhão
Infraestrutura em nuvem	US $ 1,1 milhão
Segurança cibernética	$680,000
Apoia	$720,000

Compensação profissional médica

Total de compensação profissional médica para 2023: US $ 6,8 milhões

• Compensação média por consulta: US $ 75
• Número total de profissionais médicos: 320
• Clínicos de meio período: 65%
• Clínicos em tempo integral: 35%

Marketing e aquisição de clientes

Despesas de marketing para 2023: US $ 12,3 milhões

Canal de marketing	Gastar	Percentagem
Publicidade digital	US $ 7,2 milhões	58.5%
Marketing de mídia social	US $ 3,1 milhões	25.2%
Marketing de afiliados	US $ 1,5 milhão	12.2%
Mídia tradicional	$500,000	4.1%

Conformidade regulatória e licenciamento

Custos anuais de conformidade regulatória: US $ 1,9 milhão

• Conformidade HIPAA: US $ 850.000
• Licenciamento do Conselho Médico do Estado: US $ 620.000
• Consultas legais: US $ 430.000

Infraestrutura e despesas operacionais

Despesas operacionais totais para 2023: US $ 5,6 milhões

Categoria de custo operacional	Despesa anual
Aluguel de escritório	US $ 1,2 milhão
Utilitários	$380,000
Equipe administrativo	US $ 2,7 milhões
Equipamentos e suprimentos	US $ 1,3 milhão

Lifemd, Inc. (LFMD) - Modelo de negócios: fluxos de receita

Taxas de consulta de telessaúde

A partir do quarto trimestre de 2023, a LIFEMD registrou taxas de consulta de telessaúde gerando US $ 14,2 milhões em receita.

Tipo de consulta	Taxa média	Receita anual
Consulta de atenção primária	$79	US $ 4,7 milhões
Consulta de Saúde Mental	$129	US $ 5,3 milhões
Consulta de Saúde Sexual	$99	US $ 4,2 milhões

Serviços de saúde baseados em assinatura

O modelo de assinatura da LIFEMD gerou US $ 22,3 milhões em 2023.

• Associação mensal: US $ 24,99
• Associação anual: US $ 199,99
• Total de assinantes: 37.500

Vendas de medicamentos prescritos

As vendas de prescrição atingiram US $ 18,6 milhões em 2023.

Categoria de medicação	Receita	Porcentagem de vendas
Medicamentos para perda de peso	US $ 8,4 milhões	45%
Medicamentos de saúde sexual	US $ 6,2 milhões	33%
Outras prescrições	US $ 4 milhões	22%

Reembolsos de seguros

Os reembolsos de seguros totalizaram US $ 7,9 milhões em 2023.

Monetização de dados e análises

A monetização de dados gerou US $ 3,5 milhões em receita durante 2023.

Tipo de dados	Receita
Dados do paciente anonimizado	US $ 2,1 milhões
Análise de tendências de saúde	US $ 1,4 milhão

LifeMD, Inc. (LFMD) - Canvas Business Model: Value Propositions

You're looking at the core reasons why patients choose LifeMD, Inc. over other options, and honestly, the numbers they are putting out there are what make the value proposition concrete. It's not just about convenience; it's about price leadership in key areas.

The foundation of the LifeMD offering is affordable, convenient virtual access to specialized care for over 200 conditions. This breadth covers everything from primary care to men's health, women's health, and hormone therapy, all accessible through their digital platform.

A major differentiator is the vertically integrated model. LifeMD controls the patient journey from consultation to prescription fulfillment, leveraging a proprietary digital care platform, a 50-state affiliated medical group, and an affiliated pharmacy. This structure is designed to increase access to high-quality care.

The commitment to high-quality care is reinforced by their network structure. LifeMD touts its national provider network as a key differentiator, supported by its 50-state affiliated medical group. Furthermore, management views their partnerships with pharmaceutical giants like Novo Nordisk and Eli Lilly as a 'significant and durable competitive advantage.'

For chronic condition management, the model is firmly subscription-based. As of the third quarter of 2025, LifeMD reported serving over 310,000 active telehealth subscribers. This recurring revenue base is critical, with the base LifeMD Plus membership priced at $19 monthly.

The most aggressive value proposition centers on their Weight Management Program with GLP-1 therapies. LifeMD announced in November 2025 that it will offer Wegovy and Ozempic at $199 per month for the 0.25 mg and 0.5 mg doses for new patients' first two fills, claiming this is the lowest cash-pay pricing available nationwide. This is a direct play to capture market share by offering unmatched affordability for FDA-approved medications. The overall telehealth segment is clearly driving the business, delivering $47.3 million in revenue in Q3 2025, an 18% year-over-year increase.

Here's a quick look at the pricing tiers that define the value proposition for you as a decision-maker:

Program/Service Tier	Pricing Detail	Latest Reported Amount
Base Membership (LifeMD Plus)	Monthly Subscription Fee	$19 monthly
Weight Management (GLP-1 Injections)	Starting Monthly Program Cost	From $79 monthly
Weight Management (Wegovy/Ozempic Cash-Pay)	Promotional Monthly Price (0.25mg/0.5mg, first 2 fills)	$199 per month
Weight Management (Oral Medication)	Monthly Program Cost	$129 monthly

The company's financial performance in Q3 2025 supports the scale of this model, with projected full-year 2025 revenue guidance set between $192 million and $193 million. The focus on high-margin telehealth, which saw its adjusted EBITDA rise 30% year-over-year in Q3 2025 to $2.9 million, shows that the value proposition is translating into operational leverage.

The core value drivers you should note are:

• Affordable, transparent cash-pay GLP-1 pricing at $199/month for introductory fills.
• Access to care across 200+ conditions via a 50-state network.
• A vertically integrated structure including an affiliated pharmacy.
• Base subscription access starting at $19/month.
• Serving over 310,000 active telehealth subscribers as of Q3 2025.

If onboarding takes 14+ days for new weight management patients, churn risk rises, so speed in fulfilling that $199 offer is key.

Finance: draft 13-week cash view by Friday.

LifeMD, Inc. (LFMD) - Canvas Business Model: Customer Relationships

You're looking at how LifeMD, Inc. keeps its patients engaged, which is the whole engine for their virtual care model. It's all about that direct-to-patient (D2P) connection, making sure care is continuous and feels personal, even though it's delivered digitally.

The core of this relationship is the vertically integrated digital care platform. This system isn't just a video call; it seamlessly meshes a clinician-centric electronic medical record (EMR) system with proprietary algorithms for balancing caseloads and scheduling, plus customer relationship management (CRM) functionality. This structure is designed to support personalized, continuous care across all 50 states where they operate. For example, in Q3 2025, the company ended the quarter with over 310,000 active telehealth subscribers, showing the scale of these relationships.

Subscription and membership plans are the financial backbone here. LifeMD, Inc. structures its offering around these recurring revenue streams, which is key for long-term engagement. You can see patients accessing care for as little as $39/mo via their PC or smartphone for routine, preventive care built into their virtual primary care membership programs. The growth in this area is clear: telehealth subscriber count grew by 14% year-over-year as of September 30, 2025. The RexMD business, for instance, returned to sequential growth, adding approximately 10,000 net new subscribers in that quarter alone.

Here's a quick look at the scale of the telehealth customer base as of the end of Q3 2025:

Metric	Value (Q3 2025)	Context
Active Telehealth Subscribers	Over 310,000	End of Q3 2025
Telehealth Subscriber Y/Y Growth	14%	Year-over-year as of Q3 2025
Telehealth Revenue (Q3)	$47.3 million	Q3 2025 result
RexMD Net New Subscribers (Qtr)	Approx. 10,000	Sequential growth in Q3 2025

Automated digital follow-ups and medication adherence programs are built into the platform to support these relationships post-consultation. The platform includes digital prescription capabilities and pharmacy fulfillment, which helps keep patients on track. Life sciences companies partnering with LifeMD, Inc. gain direct-to-patient capabilities across marketing and medication adherence and compliance, suggesting a structured approach to keeping patients engaged with their prescribed regimens. This focus on retention is explicitly cited as driving telehealth profitability growth.

While the model is digital, the support structure includes a U.S.-based patient care center component, though specific staffing numbers aren't public. The platform's integration of remote and in-home lab testing, alongside provider interfacing, suggests a physical/logistical backbone supporting the virtual front end for retention. Furthermore, the strategic expansion into women's health and behavioral health verticals-which management believes could each become 9-figure businesses over the next 3 years-relies heavily on successfully scaling these established D2P relationship frameworks.

The entire strategy centers on long-term engagement to drive retention and lifetime value. This is evident in their strategic positioning, such as being the only telehealth provider in the U.S. offering synchronous care and cash-pay access to both Wegovy® and Zepbound® via collaborations with major pharma partners. The goal is clearly to lock in patients through comprehensive, convenient access to high-demand therapies, moving beyond transactional visits. For instance, the company paid off approximately $17 million of debt during Q3 2025, strengthening the balance sheet to support this long-term focus.

You should track the following relationship indicators:

• Telehealth Adjusted EBITDA growth: 30% year-over-year in Q3 2025.
• Full-year 2025 revenue guidance: $192 million to $193 million.
• Gross margin remains high at 88% for Q3 2025.
• Expansion into two new verticals with 9-figure potential each over three years.

Finance: draft 13-week cash view by Friday.

LifeMD, Inc. (LFMD) - Canvas Business Model: Channels

You're looking at how LifeMD, Inc. gets its services-telehealth and prescriptions-into the hands of patients as of late 2025. Their channel strategy is heavily weighted toward digital direct-to-consumer (DTC) efforts, supported by a vertically integrated infrastructure.

Direct-to-Consumer (DTC) online advertising and digital marketing form the initial touchpoint for many new patients. The company has been working to make this spend more efficient. Advertising spend as a percentage of revenue has dropped significantly, moving from 70% in 2021 down to 48% year-to-date in 2025. This efficiency gain is a key driver in the improved profitability seen in the telehealth segment.

The brand portfolio acts as specialized entry points into the broader LifeMD ecosystem. While the full breakdown isn't public, the dedicated brand websites like RexMD, NavaMD, ShapiroMD, and Cleared drive segment-specific acquisition. For instance, the RexMD business specifically returned to growth, adding approximately 10,000 net new subscribers in the third quarter of 2025. This suggests targeted digital marketing efforts are resonating in specific verticals.

The core delivery mechanism is LifeMD's unified virtual care platform and mobile app. This platform supports the entire patient journey, from initial consultation to ongoing care management. As of September 30, 2025, LifeMD was serving approximately 310,000 active telehealth subscribers. The affiliated medical group, operating across all 50 states, has conducted over 1.3 million virtual consults as of that same date.

Fulfillment relies on an expanding mail-order pharmacy fulfillment network. LifeMD's affiliated pharmacy is a critical component of their vertical integration. The commercial pharmacy, which launched in August 2024, has the stated capacity to process up to 5,000 prescriptions per day. Furthermore, the pharmacy is currently licensed in 14 states, with plans to expand nationwide to enhance service delivery capabilities. The recent expansion into advanced non-sterile compounding, operating under the FDA's 503A designation, allows for tailored therapies and improved fulfillment economics compared to third-party partners.

The push toward payers and employers represents the potential B2B channels for employers and private payers. Management has signaled this as a key area for 2026 growth, specifically mentioning insurance enablement. The company stated they are 100% ready to go with Medicare once coverage is secured. Turning on insurance coverage has a measurable impact on acquisition costs, as it has been shown to reduce customer acquisition costs by over a third.

Here's a quick look at some key channel performance metrics from Q3 2025:

Channel Metric	Value (Q3 2025)	Context/Detail
Active Telehealth Subscribers	~310,000	Represents a 14% year-over-year increase.
Telehealth Revenue	$47.3 million	Grew 18% year-over-year.
Pharmacy Licensing Footprint	14 states	Plans for nationwide expansion.
Branded GLP-1 Cash Price (Wegovy/Ozempic)	$199 per month	For the first two fills (0.25 mg and 0.5 mg doses).
Advertising Spend as % of Revenue	48%	Year-to-date 2025 figure, down from 70% in 2021.

The company is clearly focused on driving volume through its DTC digital channels while simultaneously de-risking the model by integrating pharmacy and preparing for payer reimbursement. If onboarding takes 14+ days, churn risk rises, so the pharmacy integration is defintely key to maintaining the patient experience.

Finance: draft 13-week cash view by Friday.

LifeMD, Inc. (LFMD) - Canvas Business Model: Customer Segments

You're looking at the core patient base LifeMD, Inc. is serving as of late 2025, which is heavily weighted toward virtual, chronic care management.

The platform supports a broad base, with over 310,000 active telehealth subscribers as of September 30, 2025. This base has generated 1.3 million virtual consults conducted through the third quarter of 2025.

The customer base is segmented by need and condition:

• Cash-pay patients seeking affordable, convenient access to specialty medications.
• Individuals with chronic conditions like obesity, hair loss, and hormone imbalances.
• Men seeking health and wellness treatments (RexMD).
• Women seeking hormone, dermatology, and behavioral health services.
• Patients in all 50 states seeking virtual primary care.

The segment seeking affordable, convenient access includes patients who can see an affiliated provider for as little as $39/mo for routine, preventive care via their PC or smartphone. LifeMD, Inc. is also offering market-leading pricing for GLP-1 medications to self-pay patients.

For chronic conditions, LifeMD, Inc. offers specialized treatment across more than 200 conditions. The weight management program, which had over 75,000 patient subscribers as of December 31, 2024, is a core focus for chronic care.

The men's health vertical, RexMD, is showing traction, having returned to growth by adding approximately 10,000 net new subscribers.

The expansion into women's health and behavioral health is viewed as a major growth driver, with management labeling both as having the potential to each become 9-figure businesses over the next 3 years.

For virtual primary care, LifeMD, Inc. maintains a 50-state affiliated medical group, though they were projecting licensing in 35 states within 60-90 days as of November 17, 2025. The company's affiliated pharmacy was licensed in 49 states as of the first quarter of 2025.

Here is a breakdown of key operational metrics related to patient reach:

Metric	Value as of Late 2025	Source Context
Active Telehealth Subscribers	Over 310,000	Q3 2025 End
Total Virtual Consults Conducted	1.3 million	As of September 30, 2025
RexMD Net New Subscribers Added	Approximately 10,000	Recent Growth Period
Weight Management Subscribers	Over 75,000	As of December 31, 2024
Affiliated Medical Group Reach	50-state	Platform Capability

If onboarding takes 14+ days, churn risk rises.

Finance: draft 13-week cash view by Friday.

LifeMD, Inc. (LFMD) - Canvas Business Model: Cost Structure

You're looking at the cost side of LifeMD, Inc.'s (LFMD) operations as of late 2025, post-WorkSimpli divestiture, focusing on the core telehealth and pharmacy platform.

High customer acquisition costs (CAC) from digital marketing spend.

Concerns over rising customer acquisition costs were a factor in the period leading up to the Q3 2025 earnings report, specifically noted in relation to the RexMD segment and the sale of obesity drugs like Wegovy and Zepbound. To be fair, the company stated that turning on insurance coverage reduced customer acquisition costs by over a third. In Q2 2025, the RexMD business saw temporarily elevated CAC in the ED market, though early Q3 data suggested a return to healthier levels.

Costs of goods sold (COGS) for prescription and compounded medications.

The cost of fulfilling services directly impacts the gross margin. For the core telehealth segment in Q3 2025, the gross margin stood at 86%. This implies that the Cost of Goods Sold (COGS) for telehealth revenue, which was $47.3 million in Q3 2025, represented approximately 14% of that segment's revenue. Management noted that the overall consolidated gross margin for Q3 2025 was 88%.

Compensation for the affiliated medical group and patient care staff.

The operational cost tied to clinical services is substantial, supporting the platform's scale. LifeMD's affiliated medical group has completed 1.2 million virtual consultations. The cost of telehealth revenue, which includes physician consult fees, surged 66% year-to-date (YTD) leading up to Q3 2025, outpacing revenue growth for that period.

Technology platform maintenance and development expenses.

A significant capital outlay is directed toward vertical integration to control fulfillment costs. LifeMD, Inc. spent $10.2 million year-to-date (YTD) in 2025 to develop a wholly-owned affiliated commercial pharmacy with compounding capabilities. This move is intended to internalize fulfillment and manage the rising costs associated with medication fulfillment.

General and administrative costs, including litigation and compliance.

General and administrative expenses cover the overhead of running the enterprise. For the full fiscal year ending December 31, 2024, LifeMD, Inc. reported total Operating Expenses of $228.60M. More recently, the company recorded Restructuring Costs of $10.9Mn for the quarter ending June 2025. Furthermore, past G&A included litigation costs related to matters like the William Blair LLC case and the Harborside Advisors agreement in 2023.

Here's a quick look at the key cost-related metrics from the latest available data:

Cost Component/Metric	Value/Rate	Period/Context
Telehealth Gross Margin	86%	Q3 2025
Consolidated Gross Margin	88%	Q3 2025
Telehealth Revenue (Q3)	$47.3 million	Q3 2025
Compounding Pharmacy Investment (YTD)	$10.2 million	YTD 2025
Total Operating Expenses	$228.60M	Fiscal Year Ended 2024-12-31
Restructuring Costs (Quarterly)	$10.9Mn	June 2025
Virtual Consultations Completed	1.2 million	To date

The company's focus on vertical integration, like the new compounding pharmacy investment, is a direct response to controlling the variable costs associated with prescriptions. Also, the impact of insurance on CAC is a major lever for managing marketing spend efficiency.

• Insurance activation reduces CAC by over a third.
• Telehealth revenue growth was 18% year-over-year in Q3 2025.
• The cost of telehealth revenue surged 66% YTD leading up to Q3 2025.
• Active telehealth subscribers reached approximately 310,000 in Q3 2025.

Finance: draft 13-week cash view by Friday.

LifeMD, Inc. (LFMD) - Canvas Business Model: Revenue Streams

You're looking at the core ways LifeMD, Inc. brings in money as of late 2025. It's centered on recurring subscription revenue and product sales.

The primary driver is the recurring revenue from the telehealth platform, which supports the direct sales components of the business model.

Revenue Streams include:

• Telehealth subscription and membership fees from over 310,000 subscribers.
• Direct sales of prescription medications and compounded products.
• Sales of nutritional supplements and over-the-counter (OTC) products.

Here's the quick math on the most recent reported figures and the full-year outlook:

Revenue Component	Period/Scope	Amount
Full-Year 2025 Revenue Projection	Fiscal Year 2025 Guidance	$192 million to $193 million
Telehealth Segment Revenue	Q3 2025	$47.3 million
Total Consolidated Revenue	Q3 2025	$60.2 million
Non-Telehealth Revenue (Implied)	Q3 2025	$12.9 million

The active subscriber base provides the foundation for these revenue streams. As of the end of Q3 2025, the count stood at:

• Active Telehealth Subscribers: Approximately 310,000
• Year-over-Year Subscriber Growth: 14%

The telehealth revenue stream itself is a significant portion of the total top line, as seen in the quarterly breakdown:

• Telehealth Revenue Contribution (Q3 2025): $47.3 million
• Total Revenue (Q3 2025): $60.2 million